A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

M. Maftouh, A. Avan, N. Funel, E. Paolicchi, E. Vasile, P. Pacetti, V. Vaccaro, P. Faviana, D. Campani, S. Caponi, A. Mambrini, U. Boggi, M. Cantore, M. Milella, G.J. Peters, M. Reni, E. Giovannetti

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)609-618
JournalPharmacogenomics
Volume15
Issue number5
DOIs
Publication statusPublished - 2014

Cite this